Year-end Sale % OFF 
Abstract
Screening for albuminuria allows for early detection and treatment of individuals with chronic kidney disease (CKD), which is a risk factor for experiencing cardiovascular events (CVEs). Currently, the evidence on the cost effectiveness of screening for albuminuria in the general population is not conclusive. This study aimed to evaluate the cost effectiveness of a home-based general population screening (45-80 years old) for increased albuminuria in the Netherlands.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
